Precision
medicine aims to alter the treatments based on individual
characteristics, including differences in genetics, environment, and
lifestyle. It has the potential to transform the delivery of care for
a variety of diseases. Precision medicine implicate the application
of panomic analysis and systems biology to inspect the cause of an
individual patient's diseased condition at the molecular level and
then to apply targeted treatments to address that individual
patient's disease. Precision medicine aims to make medication and
medical practices efficient and cost effective. By using the
precision medicine, doctors recognize genetic makeup of the subject,
which helps doctors to prescribe the right drug with appropriate
dose.
Request
Sample of Report:
https://www.coherentmarketinsights.com/insight/request-sample/2422
Precision
Medicine Diagnostics Market- Drivers
Precision
medicine diagnostics market is expected to expand at rapid pace in
near future, owing to increasing number of pipeline studies to
develop new treatment for cancer. For instance, in January 2016,
University of Arkansas initiated the clinical trial for fresh tissue
biopsy to study the further advancements in bio-specimens (blood
cellular free component, e.g., plasma, serum, tissue, urine), in
order to develop precision medicine for lung cancer management and
screening (synergy with imaging). Fresh tissue biopsy involves taking
a small sample of tissue from the body part for further microscopic
examination. The study is estimated to complete in December 2019.
Precision
Medicine Diagnostics Market- Regional Analysis
On
the basis of region, the global precision medicine diagnostics market
is segmented into North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa.
Geographically,
North America accounts for the largest share in the global precision
medicine diagnostics market, owing to increasing awareness and
initiative related to precision medicine in the North America. For
instance, in 2015, the U.S Government launched the Precision Medicine
Initiative to revolutionize method to improve health and treat
disease. The precision medicine initiative will enable health care
providers to adapt new treatment and prevention strategies to
people’s unique characteristics, including their genome sequence,
micro-biome composition, health history, lifestyle, and diet.
Precision
Medicine Diagnostics Market- Key Players
Some
of the major players operating in the precision medicine diagnostics
market include Intomics, Ferrer Incode, Nanostring Technologies,
Inc., Tepnel Pharma Services, Pfizer, Inc., Novartis AG, Teva
Pharmaceuticals, Merck & Co., Inc., Qiagen N.V., and Quest
Diagnostics.
Precision
Medicine Diagnostics Market- Taxonomy
By
Technology:
-
Bioinformatics
-
Gene Sequencing
-
Drug Discovery
-
Precision Molecular Diagnostics
-
Big Data Analytics
By
Application:
-
Oncology
-
Breast cancers
-
Lung Cancer
-
Others
-
CNS
-
Hematology
-
Respiratory
-
Immunology
-
Others
Browse
In-Depth Analysis Research Report:
https://www.coherentmarketinsights.com/ongoing-insight/precision-medicine-diagnostics-market-2422
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment